Forget FAANGs - look to the US for the world's best biotech

New drug launches need private finance

The development of not one but several Covid-19 vaccines in a mere matter of months has captured the imagination of investors. With the biotechnology sector firmly in the spotlight, investors are wondering how to access the lifesaving innovation on display.

However, biotech is a deep and complex sector, which requires extensive expertise to navigate. Scientific discoveries occur in all corners of the globe, but to gain exposure to the drugs providing solutions to the world's most complex conditions, investors should look to US companies listed on the NASDAQ Biotechnology Index. In order to understand why the US has become such a biotech behemoth, investors must follow the journey from brains to business. Going for the golden mean: Now is an exciting time to have a diverse biotech portfolio All roads lead to America Innovation often ...